We are live on
!
Find out more
CAM
ClariVest Asset Management Portfolio holdings
AUM
$980M
1-Year Est. Return
60.89%
This Fund
S&P 500
This Quarter
Est. Return
+12.64%
1 Year Est. Return
+60.89%
3 Year Est. Return
+106.43%
5 Year Est. Return
+337.88%
10 Year Est. Return
+1,091.18%
AUM
$3B
AUM Growth
+$175M
(+6.2%)
Cap. Flow
-$110M
Cap. Flow
% of AUM
-3.66%
Top 10 Holdings %
Top 10 Hldgs %
32.91%
Holding
863
New
116
Increased
124
Reduced
210
Closed
111
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHW
Charles Schwab
SCHW
|
+$14.6M |
| 2 |
Olin
OLN
|
+$13.5M |
| 3 |
Dick's Sporting Goods
DKS
|
+$12.1M |
| 4 |
Old Dominion Freight Line
ODFL
|
+$9.78M |
| 5 |
Darden Restaurants
DRI
|
+$9.65M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$25.1M |
| 2 |
Eli Lilly
LLY
|
+$17M |
| 3 |
Procter & Gamble
PG
|
+$14.3M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$11.5M |
| 5 |
eBay
EBAY
|
+$10.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.15% |
| 2 | Consumer Discretionary | 18.06% |
| 3 | Healthcare | 13.51% |
| 4 | Communication Services | 9.6% |
| 5 | Industrials | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMED
451
DELISTED
Amedisys
AMED
| $397K | 0.01% |
1,621
-17,290
| -91% | -$4.54M |
|
|
BIG
452
DELISTED
Big Lots, Inc.
BIG
| $396K | 0.01% |
6,004
| – | – |
|
|
FISV
453
Fiserv Inc
FISV
$27.9B
| $386K | 0.01% |
3,610
| – | – |
|
454
Chemed
CHE
$7.22B
| $385K | 0.01% |
810
-1
| -0.1% | -$480 |
|
455
Jazz Pharmaceuticals
JAZZ
$16.7B
| $378K | 0.01% |
2,128
| – | – |
|
|
MRTX
456
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $375K | 0.01% |
2,322
+7
| +0.3% | +$1.12K |
|
|
ALLK
457
DELISTED
Allakos
ALLK
| $368K | 0.01% |
4,313
+11
| +0.3% | +$1.1K |
|
458
Sanmina
SANM
$10.9B
| $364K | 0.01% |
9,347
| – | – |
|
459
Vericel Corp
VCEL
$2.31B
| $362K | 0.01% |
6,906
-17,894
| -72% | -$1.02M |
|
460
Terreno Realty
TRNO
$7.49B
| $347K | 0.01% |
5,372
| – | – |
|
|
MRUS
461
DELISTED
Merus
MRUS
| $333K | 0.01% |
+15,807
| New | +$349K |
|
462
Bankunited
BKU
$3.36B
| $320K | 0.01% |
7,499
| – | – |
|
463
Amdocs
DOX
$6.22B
| $317K | 0.01% |
4,100
| – | – |
|
464
Urban Outfitters
URBN
$6.59B
| $317K | 0.01% |
+7,701
| New | +$290K |
|
465
Trade Desk
TTD
$6.49B
| $315K | 0.01% |
4,070
| – | – |
|
466
DHT Holdings
DHT
$3.02B
| $314K | 0.01% |
48,452
-87
| -0.2% | -$534 |
|
467
Virtu Financial
VIRT
$4.93B
| $302K | 0.01% |
10,947
| – | – |
|
468
Steel Dynamics
STLD
$37.6B
| $290K | 0.01% |
4,864
-3,345
| -41% | -$196K |
|
|
VRNT
469
DELISTED
Verint Systems
VRNT
| $279K | 0.01% |
6,183
| – | – |
|
|
ZEPP
470
Zepp Health
ZEPP
$69.7M
| $276K | 0.01% |
5,875
-135
| -2% | -$5.62K |
|
|
MPT
471
Medical Properties Trust
MPT
$2.81B
| $275K | 0.01% |
13,684
| – | – |
|
|
DQ
472
Daqo New Energy
DQ
$996M
| $273K | 0.01% |
4,200
| – | – |
|
473
Pacira BioSciences
PCRX
$997M
| $271K | 0.01% |
4,460
| – | – |
|
|
XEC
474
DELISTED
CIMAREX ENERGY CO
XEC
| $264K | 0.01% |
3,648
| – | – |
|
475
FormFactor
FORM
$9.17B
| $238K | 0.01% |
6,543
-121,881
| -95% | -$4.81M |
|
Similar funds
GCAC
D
PP
FTIS
AIA
SEC
AFG
ECM
ClariVest Asset Management's Q2 2021 Portfolio in Review
As of Q2 2021, ClariVest Asset Management held 863 positions worth $3B, up 6.2% from $2.83B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
ClariVest Asset Management withdrew a net $110M in Q2 2021, closing 111 positions and reducing 210 holdings. Its most notable exit was Amgen, an estimated $25.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 34% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, ClariVest Asset Management opened a new position in Charles Schwab worth $15M.
- ClariVest Asset Management's largest Q2 2021 buy was Charles Schwab: 206,235 shares worth $15M.
- ClariVest Asset Management added most to Olin in Q2 2021, an estimated $13.5M increase.
- ClariVest Asset Management's biggest Q2 2021 reduction was Eli Lilly, cutting an estimated $17M.
- ClariVest Asset Management fully exited Amgen in Q2 2021, selling an estimated $25.1M.
- ClariVest Asset Management's ten largest holdings make up 33% of its $3B portfolio in Q2 2021.
- ClariVest Asset Management opened 116 new positions and closed 111 in Q2 2021.
- ClariVest Asset Management's portfolio value rose 6.2% quarter-over-quarter to $3B.
Based on ClariVest Asset Management's 13F filing for Q2 2021, filed 9 Aug 2021.